An anonymous director of Curaleaf reports

CURALEAF ISSUES STATEMENT REGARDING ALTERNATIVE PROPOSAL FOR AURORA CANNABIS

Curaleaf Holdings Inc. has acknowledged the announcement by Aurora Cannabis Inc. of an alternative transaction from Organigram Global Inc.

Curaleaf's enhanced premium bid of Oct. 6, 2026, to purchase all of the outstanding common shares of Aurora remains outstanding. Curaleaf believes its offer represents better value, offering a superior combined business with a stronger capital market profile, greater certainty and speed to close, and greater anticipated synergies. Curaleaf will study Organigram's alternative transaction and awaits disclosure of material details which have not been provided, including any break fee, management and board composition going forward, and any investor rights being granted to BAT. It is also revealing that neither Aurora nor Organigram made any reference to whether the transaction is dilutive or accretive to shareholders.

Aurora's board granted due diligence access to, in Curaleaf's view, a significantly smaller, underperforming and less liquid company, burdened with a looming share overhang, a history of, and forthcoming, shareholder dilution, and weak cash generation, backed by an investor with its own disappointing cannabis investment record. In Curaleaf's view, the refusal by Aurora's board to grant Curaleaf access and engage directly blocks any chance of an enhanced Curaleaf bid and constitutes gross dereliction of their fiduciary duties.

About Curaleaf Holdings Inc.

Curaleaf is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, Curaleaf and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart and Anthem, provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf's subordinate voting shares are listed on the Toronto Stock Exchange under the symbol CURA and trade on the OTCQX market under the symbol CURLF.

We seek Safe Harbor.